Haunted by inventions?
Although the title of the piece speaks of invention, the story itself concerns journal publication [eg, He published his study, found little interest from pharmaceutical companies in his chemical, called MTA, and moved on.]
For the record, Nichols does have patents. For example,
US 6,916,832 titled Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands about compounds that are expected to be useful in treating Parkinson's disease, improving cognition, improving memory, improving the negative symptoms of schizophrenia, improving attention-deficit hyperactivity disorder and related developmental disorders, treating substance abuse disorders, and in treating various peripheral conditions where changes in dopamine receptor occupation affects physiological function, including organ perfusion, cardiovascular function, and selected endocrine and immune system functions.
0 Comments:
Post a Comment
<< Home